Observations of extensive gene expression differences in the cerebellum and potential relevance to Alzheimer's disease

被引:14
|
作者
Chappell S. [1 ]
Patel T. [1 ]
Guetta-Baranes T. [1 ]
Sang F. [2 ]
Francis P.T. [3 ]
Morgan K. [1 ]
Brookes K.J. [1 ]
机构
[1] Human Genetics, School of Life Sciences, University of Nottingham, Nottingham
[2] DeepSeq Facility, University of Nottingham, Nottingham
[3] Wolfson Centre for Age Related Diseases, King's College London, London
基金
英国医学研究理事会;
关键词
Alzheimer's disease; Cerebellum; Human brain; RNA-sequence;
D O I
10.1186/s13104-018-3732-8
中图分类号
学科分类号
摘要
Objectives: In order to determine how gene expression is altered in disease it is of fundamental importance that the global distribution of gene expression levels across the disease-free brain are understood and how differences between tissue types might inform tissue choice for investigation of altered expression in disease state. The aim of this pilot project was to use RNA-sequencing to investigate gene expression differences between five general areas of post-mortem human brain (frontal, temporal, occipital, parietal and cerebellum), and in particular changes in gene expression in the cerebellum compared to cortex regions for genes relevant to Alzheimer's disease, as the cerebellum is largely preserved from disease pathology and could be an area of interest for neuroprotective pathways. Results: General gene expression profiles were found to be similar between cortical regions of the brain, however the cerebellum presented a distinct expression profile. Focused exploration of gene expression for genes associated with Alzheimer's disease suggest that those involved in the immunity pathway show little expression in the brain. Furthermore some Alzheimer's disease associated genes display significantly different expression in the cerebellum compared with other brain regions, which might indicate potential neuroprotective measures. © 2018 The Author(s).
引用
收藏
相关论文
共 50 条
  • [1] The cerebellum in Alzheimer's disease
    Larner, AJ
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1997, 8 (04) : 203 - 209
  • [2] The allelic modulation of apolipoprotein E expression by oestrogen: potential relevance for Alzheimer's disease
    Lambert, JC
    Coyle, N
    Lendon, C
    JOURNAL OF MEDICAL GENETICS, 2004, 41 (02) : 104 - 112
  • [3] Gene expression in Alzheimer's disease
    Brooks, W
    Starkey, M
    Emson, P
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S492 - S492
  • [4] Gene expression in Alzheimer's disease
    Ermak, G
    Davies, KJA
    DRUGS OF TODAY, 2002, 38 (07) : 509 - 516
  • [5] The interneurons of the cerebellum in Alzheimer's disease
    Baloyannis, S
    Costa, V
    4TH CONGRESS OF THE EUROPEAN SOCIETY FOR CLINICAL NEUROPHARMACOLOGY, 1997, : 31 - 34
  • [6] A gene expression profile of Alzheimer's disease
    Loring, JF
    Wen, X
    Lee, JM
    Seilhamer, J
    Somogyi, R
    DNA AND CELL BIOLOGY, 2001, 20 (11) : 683 - 695
  • [7] Extensive metabolism of flavonoids relevant to their potential efficacy on Alzheimer's disease
    Xia, Hongjun
    DRUG METABOLISM REVIEWS, 2021, 53 (04) : 563 - 591
  • [8] Gene therapy in Alzheimer's disease - potential for disease modification
    Nilsson, Per
    Iwata, Nobuhisa
    Muramatsu, Shin-ichi
    Tjernberg, Lars O.
    Winblad, Bengt
    Saido, Takaomi C.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (04) : 741 - 757
  • [9] Changes in cortical gene expression in the muscarinic M1 receptor knockout mouse: potential relevance to schizophrenia, Alzheimer's disease and cognition
    Dean, Brian
    Scarr, Elizabeth
    NPJ SCHIZOPHRENIA, 2021, 7 (01):
  • [10] Changes in cortical gene expression in the muscarinic M1 receptor knockout mouse: potential relevance to schizophrenia, Alzheimer’s disease and cognition
    Brian Dean
    Elizabeth Scarr
    npj Schizophrenia, 7